Abingworth

Founded in 1973, Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs. With over $1 billion under management, it invests across all stages of development and sectors within the life sciences industry. The company supports its portfolio companies with a team of 27 based in London, Menlo Park, and Boston.

James Abell

Partner and CFO

Michael Bigham

Executive Partner

Scott Brun

Venture Partner

Shelley Chu

Partner

Lucille Conroy

Principal

Neil Cooper

CFO

Jay Cui

Principal

Brian Gallagher

Partner

Joy Ghosh Ph.D

Managing Director

Jacqueline Grant

Principal

Timothy Haines

Managing Partner

Emily Janvey MD

Managing Director

Vanessa King

Venture Partner

David Kirkpatrick

Principal

Genghis Lloyd-Harris

Partner

Diya Malhotra

Investor

Vincent Miles

Partner

Natalie Mount Ph.D

Venture Partner

Bali Muralidhar

Managing Partner

David Pinnlger

Principal

Jayson Punwani

Partner

Andrew Sinclair

Partner

Kurt von Emster

Managing Partner

Past deals in Boston, MA

Scorpion Therapeutics

Series A in 2020
Founded in 2020 and headquartered in Boston, Massachusetts, Scorpion Therapeutics is a clinical-stage biotechnology company specializing in precision oncology. It develops targeted small-molecule drugs to treat cancer by focusing on three areas: therapies against known oncogenes, agents for currently undruggable targets, and drugs for new targets.

Nido Biosciences

Venture Round in 2020
Nido Biosciences is a clinical-stage biopharmaceutical company based in Boston, Massachusetts, focused on developing precision medicines and small-molecule therapeutics for severe neurological and neuromuscular diseases. It employs a functional genomics platform using human cell lines and tailored screens to identify therapeutic targets driven by human genetics, with the aim of addressing the underlying biology of disease and restoring healthy cell function through targeted interventions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.